Interleukin-2 gene therapy potentiates tha antitumor effect of cytostatic agent in mice with advanced transplantable tumors

• Authors: E. Pajtasz-Piasecka , C. Radzikowski
• Languages of publication: EN

Abstracts

EN

The combination of one dose of the cytostatic agent (bromoanalog of ifosfamide) administration with subsequent peritumoral injections of the cytokine-producing cells was observed to be more efficient in the tumor growth inhibition as compared with the cytostatic alone.

Keywords

EN

CHEMIOIMMUNOTHERAPY; COLON CARCINOMA; FIBROSARCOME; IMMUNOTHERAPY; INTERLEUKIN

Discipline

• BIOTECHNOLOGY: BIOTECHNOLOGY

• Publisher: Committee of Biotechnology, Polish Academy of Sciences
• Journal: Biotechnologia
• Year: 1996
• Issue: 4
• Pages: 68-79

Contributors

author

E. Pajtasz-Piasecka

author

C. Radzikowski

• Document Type: article
• Publication order reference: H.Glazman-Kusnierczyk, Dept. of Tumor Immunology, L.Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Czerska St. 12, 53-114 Wroclaw, Poland